Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: A randomized, double-blind equivalence, placebo-controlled trial

British Journal of Clinical Pharmacology

Volumn 54, Issue 6, 2002, Pages 652-656

  Autret Leca, Elisabeth ^a,b   Giraudeau, Bruno ^a   Ployet, Marie Joseph ^a   Jonville B́ra, Annie Pierre ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Acute otitis media; Amoxicillin clavulanic acid; Children; Randomized trial; Upper respiratory tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PLACEBO;

ANAMNESIS; ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTITIS MEDIA; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SKIN DISEASE; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ACUTE DISEASE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; INFANT; OTITIS MEDIA; RECURRENCE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 0036902523     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.t01-6-01689.x     Document Type: Article

References (16)

1. Erramouspe J, Heyneman A. Treatment and prevention of otitis media. Ann Pharmacother 2000; 34: 1452-1468.
2. Cohen R. Enquête nationale sur les critères de prescription d'une antibiothérapie dans les rhinopharyngites en pédiatrie de ville. Annales Pediatrie 1992; 39: 195-201.
3. Guillemot D, Carbon C, Vauzelle-Kervroedan F,et al. Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998; 51: 61-68.
4. Uhari M, Mätysaari K, Niemelä M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis 1996; 22: 1079-1083.
5. Taylor B, Abbot GD, Kerr MM, Fergusson DM. Amoxicillin and cotrimoxazole of presumed viral respiratory infections in childhood: Placebo-controlled trial. Br Med J 1997; 2: 552-554.
6. Todd JK, Todd N, Dammato J, Todd WA. Bacteriology and treatment of purulent nasopharyngitis: A double blind, placebo controlled evaluation. Pediatr Infect Dis J 1984; 3: 226-232.
7. Heikkinen T, Ruuskanen O, Ziegler T, Waris M, Puhakka H. Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media. J Pediatr 1995; 126: 313-316.
8. Fogle-Hansson M, White P, Hermansson A, Prellner K. Short term penicillin-V prophylaxis did not prevent acute otitis media in infants. Int J Pediatr Otorhinolaryngol 2001; 59: 119-123.
9. Little PS, Williamson I. Are antibiotics appropriate for sore throats? Costs outweigh the benefits. Br Med J 1994; 309: 1010-1012.
10. Guillemot D, Maison P, Carbon C,et al. Trends in antimicrobial drug use in the community - France 1981-92. J Infect Dis 1998; 177: 492-497.
11. Auckenthaler R. Common cold: Diagnostic steps? Antibiotics? Ther Umsch 1992; 49: 211-215.
12. Paradise JL. On classifying otitis media as suppurative or nonsuppurative, with a suggested clinical schema. J Pediatr 1987; 111: 948-951.
13. Dunnett CW, Gent M. Significance testing to establish equivalence between treatments with special reference to data in the form of 2 × 2 tables. Biometrics 1977; 33: 593-602.
14. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: The importance of rigorous methods. Br Med J 1996;313: 36-39.
15. Geslin P. Bêta-lactamines et pneumocoques multi-résistants isolés en France (1984-94). Médecine Hygiène 1995; 53: 2111-2118.
16. Guillemot D, Carbon C, Balkau B,et al. Low dosage and long treatment duration of beta-lactam: Risk factors for carriage of penicillin-resistantStreptococcus pneumoniae. JAMA 1998; 279: 365-370.